Immune restoration following hematopoietic stem cell transplantation: an evolving target
Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation
Autologous hematopoietic stem cell transplantation for autoimmune diseases
Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment
Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998
rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
Successful allogeneic bone marrow transplantation in a patient with active Coccidioidomycosis
Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation
Allogeneic transplantation for hepatosplenic αβ T-cell lymphoma